John G Ullman & Associates Inc. Grows Position in Azenta, Inc. (NASDAQ:AZTA)

John G Ullman & Associates Inc. increased its position in Azenta, Inc. (NASDAQ:AZTA) by 40.1% in the fourth quarter, HoldingsChannel reports. The firm owned 111,825 shares of the company’s stock after purchasing an additional 32,032 shares during the quarter. John G Ullman & Associates Inc.’s holdings in Azenta were worth $5,591,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in AZTA. Farther Finance Advisors LLC lifted its stake in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after purchasing an additional 256 shares during the period. KBC Group NV increased its position in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after buying an additional 698 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Azenta during the 4th quarter valued at approximately $200,000. Aigen Investment Management LP bought a new position in Azenta during the 3rd quarter valued at approximately $214,000. Finally, Empowered Funds LLC bought a new position in Azenta during the 4th quarter valued at approximately $293,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Trading Up 1.6 %

Azenta stock opened at $43.62 on Friday. The firm has a market cap of $1.99 billion, a price-to-earnings ratio of -14.64 and a beta of 1.47. The stock has a fifty day simple moving average of $50.17 and a two-hundred day simple moving average of $47.71. Azenta, Inc. has a 12 month low of $38.82 and a 12 month high of $67.77.

Azenta (NASDAQ:AZTA) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, equities research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on AZTA shares. Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research report on Thursday, February 6th. TD Cowen raised Azenta to a “hold” rating in a research report on Thursday. Stephens reaffirmed an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Finally, Evercore ISI raised their price objective on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Azenta currently has a consensus rating of “Hold” and an average target price of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.